Severity
Low
FDA Drug recall · Reported July 8, 2015
Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.
Qualitest Pharmaceuticals recalled Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qual… - a low-severity action.
Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qual… was recalled by Qualitest Pharmaceuticals in July 8, 2015. Reason: Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product …. Check the official notice for the remedy. Verify recall #D1151-2015 with the FDA Drug before acting.
The recall
Qualitest Pharmaceuticals issued this low-severity FDA Drug recall-Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product ….
Sourced from official FDA Drug enforcement records. Verify recall #D1151-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D1151-2015) was formally reported on July 8, 2015, with the manufacturer initiating the action on June 18, 2015. It is classified under Low severity (Class III), with a current status of Terminated. Qualitest Pharmaceuticals is listed as the recalling firm, operating out of Huntsville, AL. Federal records list the affected scope as 2016 bottles.
The documented reason for this recall is: Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution. Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
2016 bottles
Related Recalls
6
5 from same agency
Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qualitest Pharmaceuticals 130 Vintage Drive Huntsville, AL 35811. NDC 0603-3432-21.
Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D1151-2015 |
| Date reported | July 8, 2015 |
| Date initiated | June 18, 2015 |
| Recalling firm | Qualitest Pharmaceuticals |
| Firm location | Huntsville, AL |
| Affected scope | 2016 bottles |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported July 8, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.